---
figid: PMC6332919__SCIENTIFICA2018-5036213.001
figtitle: MAPK signalling pathway and its inhibitors
organisms:
- Homo sapiens
pmcid: PMC6332919
filename: SCIENTIFICA2018-5036213.001.jpg
figlink: /pmc/articles/PMC6332919/figure/fig1/
number: F1
caption: MAPK signalling pathway and its inhibitors.
papertitle: Cutaneous Side Effects of Targeted Therapy and Immunotherapy for Advanced
  Melanoma.
reftext: Irene Russo, et al. Scientifica (Cairo). 2018;2018:5036213.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9223481
figid_alias: PMC6332919__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6332919__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6332919__SCIENTIFICA2018-5036213.001.html
  '@type': Dataset
  description: MAPK signalling pathway and its inhibitors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - NRAS
  - BRAF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - Tyrosine
  - Vemurafenib
  - Dabrafenib
  - Trametinib
  - Cobimetinib
---
